Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The study is designed to compare the abuse liabilities of intranasal buprenorphine and
buprenorphine/naloxone in individuals who are physically dependent on sublingual
buprenorphine. The investigators hypothesize that the abuse liability of
buprenorphine/naloxone is lower than that of buprenorphine alone.
Phase:
Phase 3
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
Indivior Inc.
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Heroin Naloxone